Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
20.0%
% of MEDX's 30 holdings also in SYNB
17.6%
% of SYNB's 36 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus SYNB)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in SYNB |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 9.2% | 5.1% | 5.1% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.5% | 4.2% | 4.2% |
|
ELI LILLY & CO | 17.4% | 4.1% | 4.1% |
|
REGENERON PHARMACEUTICALS | 3.0% | 2.6% | 2.6% |
|
ALNYLAM PHARMACEUTICALS INC | 4.3% | 1.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to SYNB
|
ELI LILLY & CO | 13.3% |
 |
NOVARTIS AG-ADR | 6.2% |
|
AMGEN INC | 6.0% |
|
BRISTOL-MYERS SQUIBB CO | 5.9% |
|
JOHNSON & JOHNSON | 4.9% |
 |
ALKERMES PLC | 4.8% |
|
ABBVIE INC | 4.0% |
|
PFIZER INC | 4.0% |
|
MERCK & CO. INC. | 3.6% |
|
ALNYLAM PHARMACEUTICALS INC | 3.2% |
MEDX Underweight Relative to SYNB
|
THERMO FISHER SCIENTIFIC INC | -6.9% |
|
NVIDIA CORP | -5.8% |
|
DANAHER CORP | -5.6% |
|
CORTEVA INC | -5.3% |
|
BIO-RAD LABORATORIES-CL A | -5.0% |
 |
NOVOZYMES A/S-UNSPONS ADR | -4.7% |
|
ALPHABET INC. CLASS A | -4.3% |
|
ASCENDIS PHARMA A/S | -4.1% |
|
DUPONT DE NEMOURS INC | -3.8% |
|
CADENCE DESIGN SYS INC | -3.5% |